"Kabi" Ambi-Implantable Injection System - Taiwan Registration 237090ec4422d2a934635232a3f7d7e2
Access comprehensive regulatory information for "Kabi" Ambi-Implantable Injection System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 237090ec4422d2a934635232a3f7d7e2 and manufactured by Fresenius Kabi AG;; CLINICO MEDICAL SP. Z.O.O. BลONIE NEAR WROCลAW. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
237090ec4422d2a934635232a3f7d7e2
DHA05603035100
Product Details
For details, it is Chinese approved copy of the imitation order
J General hospital and personal use equipment
J.5965 Subcutaneous implantable intravascular injection port and guide
import
Dates and Status
Oct 18, 2017
Oct 18, 2027